https://www.selleckchem.com/pr....oducts/lipofermata.h
rganized campaigns; political and policy entrepreneurs, and compelling issue framing. The European Medicines Agency (EMA) aims to resolve uncertainties associated with conditionally approved drugs by imposing post-approval studies. Results from these studies may be relevant for health technology assessment (HTA) organizations. This study investigated the role of regulator-imposed post-approval studies within HTA. For all conditionally approved drugs up to December 2018, regulator-imposed post-approval studies were identified from EM
Like
Comment
Share
